Takeda Pharmaceutical (TAK) EBT Margin (QoQ) (2018 - 2026)
Takeda Pharmaceutical (TAK) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -5,043.00 |
| Sep 30, 2025 | -129.00 |
| Jun 30, 2025 | -231.00 |
| Mar 31, 2025 | 2,265.00 |
| Dec 31, 2024 | -1,819.00 |
| Sep 30, 2024 | -330.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 675.00 |
| Dec 31, 2023 | -563.00 |
| Sep 30, 2023 | -257.00 |
| Jun 30, 2023 | -193.00 |
| Mar 31, 2023 | 492.00 |
| Dec 31, 2022 | 333.00 |
| Sep 30, 2022 | -955.00 |
| Jun 30, 2022 | -694.00 |
| Mar 31, 2022 | 1,492.00 |
| Dec 31, 2021 | 74.00 |
| Sep 30, 2021 | -1,621.00 |
| Jun 30, 2021 | 649.00 |